Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Implications for registry-based vaccine effectiveness studies from an evaluation of an immunization registry: A cross-sectional study

  • Barbara E Mahon1, 2, 4Email author,
  • Kimberly M Shea1,
  • Nancy N Dougherty2, 4 and
  • Anita M Loughlin1, 2, 3
BMC Public Health20088:160

DOI: 10.1186/1471-2458-8-160

Received: 15 November 2007

Accepted: 14 May 2008

Published: 14 May 2008

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
15 Nov 2007 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
13 Dec 2007 Reviewed Reviewer Report - Kim Rask
8 Jan 2008 Reviewed Reviewer Report - Steve Berman
2 Mar 2008 Author responded Author comments - Barbara Mahon
Resubmission - Version 3
2 Mar 2008 Submitted Manuscript version 3
26 Mar 2008 Reviewed Reviewer Report - Steve Berman
30 Apr 2008 Author responded Author comments - Barbara Mahon
Resubmission - Version 4
30 Apr 2008 Submitted Manuscript version 4
Publishing
14 May 2008 Editorially accepted
14 May 2008 Article published 10.1186/1471-2458-8-160

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Epidemiology, Boston University School of Public Health
(2)
Department of Pediatrics, Boston University School of Medicine
(3)
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health
(4)
Novartis Vaccines

Advertisement